Skip to content

Optic Coherence Tomography in Patients With Amyotrophic Lateral Sclerosis

Optic Coherence Tomography in Patients With Amyotrophic Lateral Sclerosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03377868
Enrollment
30
Registered
2017-12-19
Start date
2018-01-03
Completion date
2018-09-28
Last updated
2017-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Brief summary

Amyotrophic Lateral Sclerosis (ALS) is an adult-onset, devastating, neurodegenerative disease characterized by the loss of cortical, brain stem, and spinal motor neurons. Visual evoked potentials studies in patients with ALS suggest visual pathway involvement. Optic coherence tomography (OCT) is a non-invasive cross-sectional imaging modality measuring the optical reflections in biological tissues. The main objective of this observational cohort study is to explore the correlation between changes on OCT retinal parameters and and clinical disability as measured by the ALS Functional Rating Scale (ALS-FRS-r) in patients with ALS at baseline, 3 and 6 months. A secondary objective is to explore the correlation between changes in retinal OCT parameters and pulmonary function tests (FVC and FEV1) in this cohort of patients with ALS. A parallel cohort of healthy age and sex matched subjects will participate as controls to obtain reference values of their retinal layers' thickness at baseline, 3 and 6 months.

Interventions

Optic coherence tomography measures retinal layer thickness, macular volume , and cell inner plexiform layer.

DIAGNOSTIC_TESTPulmonary function test

Pulmonary function test measures forced vital capacity and forced expiratory volume in one second.

Sponsors

American University of Beirut Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Observational study of a cohort of patients with amyotrophic lateral sclerosis compared to a parallel cohort of healthy age and sex matched subjects

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of ALS according to the El Escorial criteria. * Age 18 years to 80 years old * Disease duration less than 36 months * Patients logistically able to attend and be evaluated at baseline, 3 and 6 months

Exclusion criteria

* Patients with diabetes mellitus * Patients with glaucoma, refractive errors of ± 6 diopters or more, or other ophthalmologic disorders such as media opacities that could interfere with retinal OCT assessment

Design outcomes

Primary

MeasureTime frameDescription
Change in retinal layer thickness parameters over 3 and 6 months in ALS patients6 monthsObserving the change in retinal layers thickness parameters in micrometers in ALS patients from baseline to 3 and 6 months

Secondary

MeasureTime frameDescription
Comparison of changes in retinal layer thickness parameters over 3 and 6 months between ALS patients and their healthy controls6 monthComparison of changes in retinal layer thickness parameters over 3 and 6 months between ALS patients and their healthy controls in micrometers
Correlation between changes in retinal layers thickness and ALS-FRS scores in patients with ALS6 monthCorrelation between changes in retinal layers thickness in micrometers and ALS-FRS scores in ALS patients over 3 and 6 month
Correlation between changes in retinal layers thickness and Pulmonary function test parameters in ALS patients over 3 and 6 months6 monthCorrelation between changes in retinal layers thickness parameters in micrometers and changes in FEV1 in liters and FVC in liters on pulmonary function testing in patients with ALS over 3 and 6 month

Contacts

Primary ContactAchraf Makki, MD
am132@aub.edu.lb+9611350000
Backup ContactElia Malek, MD
em26@aub.edu.lb

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026